Back to Agenda
Roundtable Discussions
Session Chair(s)
Roundtable Discussion
United States
Each day’s networking luncheon offers both open seating and focused roundtable discussions. Each topic listed below will be hosted at a designated table led by a moderator. If you’re passionate about one of these subjects or would like to exchange ideas with peers who share similar interests, we invite you to join a designated table to enjoy both your meal and an engaging conversation.
Uncovering the Bottleneck in the Canadian Clinical Trials Ecosystem by Suzie Talbot, Diex Research, Jean-Francois Leger, Sanofi and Bruno Battistini, University of Ottawa
The panelists from Session 3B will continue the discussion around the challenges and opportunities related site feasibility, selection, and recruitment using AI.
Meet Your Health Canada Clinical Trial Inspectors: Collaborating Towards a Successful GCP Inspection hosted by Kevin Donato, Health Canada and Hocine Abid, Health Canada
To continue on the topic of a proportionate risk-based inspection approach, Health Canada’s clinical trial Inspectors will host a roundtable on the inspection process and preparation for a successful clinical trial inspection.
Documents to Data, Advancing Digitization - Current Status and Future Vision hosted by Todd Georgieff, RWS
Join us to continue a discussion about enabling real-time, data- and content-based submissions based on interoperability standards including HL7 FHIR, CDISC, OMOP and others.
A Closer Look at Canada’s Post-Market Drug Evaluation Program hosted by Michael Paterson, Institute for Clinical Evaluative Sciences and Tarry Ahuja, Canada Drug Agency
Join us for a roundtable discussion that offers a deeper exploration of Canada’s Drug Agency Post-Market Drug Evaluation (PMDE) Program, its key stakeholders, and its role in supporting evidence-based decision-making. The session will also highlight CoLab — a national expert network — including its structure and collaborative contributions to post-market drug evaluation.
Meet Your Health Canada Clinical Trial Reviewers: Collaborating Towards a Successful Clinical Trial Application hosted by Katherine Soltys, Health Canada and Sophie Hamel, Health Canada
To answer any questions you may have on Health Canada’s clinical trial application (CTA) process, representatives from Health Canada’s Office of clinical trials will host a roundtable on the preparation for a successful CTA.
Have an account?